• Contact

  • Newsletter

  • About us

  • Delivery options

  • Prospero Book Market Podcast

  • News

  • Acetylcholine in Alzheimer's Disease and Related Dementias

    Acetylcholine in Alzheimer's Disease and Related Dementias by Zaborszky, Laszlo; Ovsepian, Saak V.;

      • GET 20% OFF

      • The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
      • Publisher's listprice EUR 153.00
      • The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

        64 902 Ft (61 812 Ft + 5% VAT)
      • Discount 20% (cc. 12 980 Ft off)
      • Discounted price 51 922 Ft (49 450 Ft + 5% VAT)

    64 902 Ft

    db

    Availability

    Not yet published.

    Why don't you give exact delivery time?

    Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.

    Product details:

    • Publisher Academic Press
    • Date of Publication 1 September 2025

    • ISBN 9780128244913
    • Binding Paperback
    • No. of pages350 pages
    • Size 228x152 mm
    • Language English
    • Illustrations Approx. 150 illustrations (150 in full color)
    • 700

    Categories

    Long description:

    Acetylcholine in Alzheimer's Disease and Related Dementias surveys the current state of knowledge on the cholinergic system in rodents, primates and humans. The book's authors discuss aging and AD from system, cellular, molecular and genetic aspects. The book critically evaluates the role of the cholinergic system as it relates to clinical symptoms, therapy and pathogenesis. It follows the history of the cholinergic hypothesis of memory and AD from the seventies/early eighties of the previous century to the current view of disease-modifying roles. The book promotes the idea that the organization of the cholinergic system and its purported homeostatic role may contribute to its higher vulnerability to amyloid pathology of AD.Finally, it discusses current trends of AD prevention from a functional medicine perspective.

    More

    Table of Contents:

    1. Anatomy of the basal forebrain cholinergic (BFC) system in rodents and primates, including humans 2. Input-output relations of BFC neurons 3. Cholinergic receptors: neurobiology and functions 4. Dementias 5. Neuropathology of AD 6. Cholinergic deficit in AD 7. Relationship between cholinergic loss, pathological lesions in AD and dementia 8. Progression of the disease, clinical-pathological correlations in MCI/AD 9. Pathology of the aging brain in relation to AD 10. Amyloid deposition with large-scale human network dysfunctions in aging and AD 11. APP processing, ß-amyloid, a,ß,? secretases, notch signaling 12. ?-amyloid production, secretion, oligomerization, clearance/export, degradation 13. Synaptic vesicle cycle and ß-amyloid: intracellular trafficking, retromer sorting, autophagy 14. Tau phosphorylation, NFTs, axonal transport 15. The wnt-GSK-3 signaling, presenilin, tau 16. Apolipoprotein, LRP receptors, lipid homeostasis 17. ApoE alleles, gene mutations in AD 18. Microglia activation, inflammation 19. Epigenetic mechanisms in AD 20. Transgenic mice models in AD 21. Pathogenetic (mechanistic) schemes 22. Current therapies in AD 23. Vulnerability and repair of BFC neurons, early attempts 24. Biochemical pathways linking muscarinic, nicotinic receptors with APP cleavage and phosphorylation of tau 25. NGF, TrkA, p75, neurobiology, transport and signaling in cholinergic neurons 26. Homeostatic clearance of Aß mediated via p75 receptor uptake and degradation in BFC neurons 27. Cell cycle proteins in BFC cells 28. Dual, neuromodulator and homeostatic role of BFC system 29. Atrophy of BFC compartments and relation to cognitive impairment in MCI/AD 30. Volume of Ch1/2 is predictor of conversion from MCI to AD 31. Summary and concluding remarks

    More